
Dr. Hartwig is a thoracic surgeon with a clinical focus in robotic assisted minimally invasive thoracic surgery for the treatment of diseases of the chest. He serves as the Surgical Director of the Esophageal Center at Duke. He is also the Director of the Minimally Invasive Thoracic Surgery Fellowship at Duke, while providing advanced instruction in robotic surgery to surgeons around the world. He also leads a successful program of clinical, basic and translational research in thoracic surgery and lung transplantation. He currently directs the Duke Ex Vivo Organ Laboratory (DEVOL), is the Chief of Lung Transplant Research, and is a faculty member at the Duke Clinical Research Institute (DCRI).
Dr. Hartwig has over 150 peer reviewed publications, received numerous awards, chaired many sessions at national and international meetings, serves regularly on NIH study sections, and is on the editorial board of many prominent journals. He has also personally mentored over pre-and post-doctoral trainees, many of whom are now engaged in their own successful research careers.
Education and Training
- Chief Resident, Duke University, 2010 - 2011
- Resident, Duke University, 2008 - 2010
- Chief Resident, Duke University, 2007 - 2008
- Senior Assistant Resident, Duke University, 2005 - 2007
- Research Fellow, Duke University, 2003 - 2005
- Junior Assistant Resident, Duke University, 2002 - 2003
- Intern, Duke University, 2001 - 2002
- M.D., Duke University, 2001
In the News
- Poorer black patients have lower survival from esophageal cancerFebruary 1, 2016
- Survival Period for Esophageal Cancer Is Tied to Race and IncomeJanuary 27, 2016
Selected Grants
- Lung Transplant Clinical Trial Network (LT-CTN)
- Study Title: Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
Internal Reference Number / Short title: TEAMMATE - PROTOCOL PGX-004 OBSERVATIONAL STUDY OF LUNG PRESERVATION
- Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility
- The Organ Care System (OCS) Lung Thoracic Organ Perfusion (TOP) Post Approval Study (PAS) Registry - OCS Lung TOP PAS Registry
- A Prospective, Multi-Center Investigation of the da Vinci SP® Surgical System in Pulmonary Lobectomy and Thymectomy for Benign and Malignant Disease
- Duke CTSA (TL1) Year 5
- TransMedics Lungs for Transplantation EXPAND II Trial
- Cystic Fibrosis Lung Transplant Consortium
- BMI Service Agreement
- FSF Fellowship
- Expand Trial
- Long Term Follow up of the Lung Transplant Outcomes Group Cohort
- Objective Lung Assessment Tools For Improved Organ Use In Lung Transplantation
- FSF Fellowship
- Retrospective Lobectomy
- Polarean - POL-Xe-002 Study
- LINX After Lung Transplantation
- Polarean - POL-XE-001 Study
- A Phase 2, Multicenter, Open Label Study To Measure Safety Donor Lungs (EVLP)
- Cystic Fibrosis Lung Transplant Consortium
- ExVivo Lung Study ¿ Biocompatibility Assessment of ExVivo Disposable Perfusion Kit with Nitric Oxide and/or MP3964
- Clinical Risk Factors for Primary Graft Dysfunction
- FSF Fellowship
- Obesity, Inflammation, and Lung Injury after Lung Transplantation
- Prospective Registry of Outcomes in Patients Electing Lung Transplantation (PROPEL)
- More and Better Lungs: Ex-Vivo Perfusion of Non-Heart-Beating Donors?